Macrophages are terminally differentiated innate immune cells. Through their activation,
they can be polarized towards the pro-inflammatory M1 type or the wound healing …

Immunomodulatory drugs (IMiDs) lenalidomide and pomalidomide show remarkable
antitumor activity in multiple myeloma (MM) via directly inhibiting MM-cell growth in the bone …

BAG3, also known as BIS and CAIR-1, interacts with Hsp70 via its BAG domain and with
other molecules through its WW domain, PXXP repeats and IPV motifs. BAG3 can participate …

For advanced, refractory endometrial cancer (EC), it is advisable to find effective
immunotherapeutic targets. In the present study, genes affecting the immune status of …

Background Galectin‐9 and myeloid‐derived suppressor cells (MDSCs) have an important
role in tumors, but their clinical values in chronic lymphocytic leukemia (CLL) have not been …

Simple Summary There are still very few studies on Galectin-9 (Gal-9) in chronic lymphocytic
leukemia (CLL), and the effect of Gal-9 on CLL pathogenesis. This study considers the …

Abstract Acute Myeloid Leukemia (AML) is a heterogeneous disease with highest mortality
compared to other types of leukemia. There is a need to find the gene abnormalities and …

Multidrug resistance (MDR) is a major challenge in leukemia treatment. The objective of this
study was to identity predictors of MDR to allow for rapid and economical assessment of the …

Lymphomas comprise a heterogeneous group of diseases with variable clinical
presentations, pathological features, and prognoses. In lymphoma diagnosis, flow cytometry …

Background Lymphocytic leukemia (LL) is a primary malignant tumor of hematopoietic
tissue, which seriously affects the health of children and the elderly. The study aims to …